Mabion S.A. (WSE:MAB)
7.77
-0.45 (-5.47%)
Apr 28, 2026, 5:03 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 125.58 million as of April 28, 2026. Its market cap has decreased by -16.27% in one year.
Market Cap
125.58M
Enterprise Value
123.89M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.77
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 125.58M, an increase of 35.02%. That is a compound annual growth rate of 1.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 132.85M | 17.77% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 553.73M |
| Captor Therapeutics Spolka Akcyjna | 508.27M |
| Bioceltix | 408.24M |
| BIOTON | 359.34M |
| Synthaverse | 236.37M |
| Molecure | 118.06M |
| NanoGroup | 108.28M |
| Poltreg | 80.21M |